COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature

Future Oncology

Volumn 8, Issue 8, 2012, Pages 1031-1040

  Chapman, Karen B ^a   Prendes, Maria J ^b   Sternberg, Hal ^b   Kidd, Jennifer L ^b   Funk, Walter D ^b   Wagner, Joseph ^a   West, Michael D ^b  

^a OncoCyte Corporation   (United States)

^b BIOTIME INC   (United States)

Author keywords

biomarker; cancer; COL10A1; collagen X; endothelium; pan cancer; tumor angiogenesis; tumor microenvironment

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 10 A1; COLLAGEN TYPE 8; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; BRAIN; BREAST; CANCER CELL CULTURE; ENDOMETRIUM; ESOPHAGUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY; LIVER; LUNG; LYMPH NODE; MULTIPLE CANCER; OVARY; PANCREAS; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLID TUMOR; STOMACH; TESTIS; TUMOR CELL LINE; TUMOR VASCULARIZATION; UPREGULATION;

CELL LINE, TUMOR; COLLAGEN TYPE X; COLLAGEN TYPE XI; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS;

EID: 84865222113     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.79     Document Type: Article

References (32)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646-674 (2011).
2. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193), 2011-2015 (1994).
3. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277(5328), 955-959 (1997).
4. Kielty CM, Kwan AP, Holmes DF, Schor SL, Grant ME. Type X collagen, a product of hypertrophic chondrocytes. Biochem. J. 227(2), 545-554 (1985).
5. Reginato AM, Lash JW, Jimenez SA. Biosynthetic expression of type X collagen in embryonic chick sternum cartilage during development. J. Biol. Chem. 261(6), 2897-2904 (1986).
6. Nerlich AG, Kirsch T, Wiest I, Betz P, Von Der Mark K. Localization of collagen X in human fetal and juvenile articular cartilage and bone. Histochemistry 98(5), 275-281 (1992).
7. Gebhard S, Hattori T, Bauer E et al. BAC constructs in transgenic reporter mouse lines control efficient and specific LacZ expression in hypertrophic chondrocytes under the complete Col10a1 promoter. Histochem. Cell. Biol. 127(2), 183-194 (2007).
8. Maye P, Fu Y, Butler DL et al. Generation and characterization of Col10a1-mcherry reporter mice. Genesis 49(5), 410-418 (2011).
9. Grant WT, Wang GJ, Balian G. Type X collagen synthesis during endochondral ossification in fracture repair. J. Biol. Chem. 262(20), 9844-9849 (1987).
10. Topping RE, Bolander ME, Balian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clin. Orthop. Relat. Res. (308), 220-228 (1994).
11. Hoyland JA, Thomas JT, Donn R et al. Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner. 15(2), 151-163 (1991).
12. Wallis GA, Rash B, Sweetman WA et al. Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the a 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid. Am. J. Hum. Genet. 54(2), 169-178 (1994).
13. Wallis GA, Rash B, Sykes B et al. Mutations within the gene encoding the a 1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia. J. Med. Genet. 33(6), 450-457 (1996).
14. Jacenko O, Roberts DW, Campbell MR, McManus PM, Gress CJ, Tao Z. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X. Am. J. Pathol. 160(6), 2019-2034 (2002).
15. Sweeney E, Roberts D, Corbo T, Jacenko O. Congenic mice confirm that collagen X is required for proper hematopoietic development. PLoS ONE 5(3), e9518 (2010).
16. Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol. Rep. 22(5), 1119-1127 (2009).
17. Vuorio E, De Crombrugghe B. The family of collagen genes. Annu. Rev. Biochem. 59, 837-872 (1990).
18. Sinha S, Kielty CM, Heagerty AM, Canfield AE, Shuttleworth CA. Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis. Int. J. Exp. Pathol. 82(5), 295-302 (2001).
19. Sage H, Pritzl P, Bornstein P. A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry 19(25), 5747-5755 (1980).
20. Pelttari K, Winter A, Steck E et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 54(10), 3254-3266 (2006).
21. Kidd S, Spaeth E, Dembinski JL et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem. Cells 27(10), 2614-2623 (2009).
22. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162), 557-563 (2007).
23. Silva GV, Litovsky S, Assad JA et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111(2), 150-156 (2005).
24. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893), 41-49 (2002).
25. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3), 301-313 (2008).
26. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin. Thromb. Hemost. 36(3), 321-331 (2010).
27. Hashizume H, Baluk P, Morikawa S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156(4), 1363-1380 (2000).
28. Papadimitrou JM, Woods AE. Structural and functional characteristics of the microcirculation in neoplasms. J. Pathol. 116(2), 65-72 (1975).
29. Steinberg F, Konerding MA, Streffer C. The vascular architecture of human xenotransplanted tumors: histological, morphometrical, and ultrastructural studies. J. Cancer Res. Clin. Oncol. 116(5), 517-524 (1990).
30. Kaplan RN, Riba RD, Zacharoulis S et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069), 820-827 (2005).
31. Van Dongen GA, Visser GW, Lub-De Hooge MN, De Vries EG, Perk LR. Immuno-PET: a navigator in monoclonal antibody development and applications. Oncologist 12(12), 1379-1389 (2007).
32. Choudhary S, Mathew M, Verma RS. Therapeutic potential of anticancer immunotoxins. Drug Discov. Today 16(11-12), 495-503 (2011).